Author:
Cheng Jingjing,Qian Dong,Ding Xiaofeng,Song Tianqiang,Cai Muyan,Dan Xie ,Wang Yuwen,Zhao Jinlin,Liu Zhuang,Wu Zhiqiang,Pang Qingsong,Zhu Li,Wang Ping,Hao Xishan,Yuan Zhiyong
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference48 articles.
1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA. 68, 7–30 (2018).
2. Chen, W. et al. Cancer statistics in China, 2015. CA. 66, 115–132 (2016).
3. Llovet, J. M. & Hernandez-Gea, V. Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design. Clin. Cancer Res. 20, 2072–2079 (2014).
4. Marquardt, J. U. & Thorgeirsson, S. S. SnapShot: hepatocellular carcinoma. Cancer Cell. 25, 550e551 (2014).
5. Subbotin, V. M. Privileged portal metastasis of hepatocellular carcinoma in light of the coevolution of a visceral portal system and liver in the chordate lineage: a search for therapeutic targets. Drug Discov. Today 23, 548–564 (2018).
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献